Shopping Cart 0
Cart Subtotal
USD 0

Cleveland BioLabs Inc (CBLI)-Medical Equipment-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Cleveland BioLabs Inc (Cleveland) is a biopharmaceutical company that develops and commercializes drugs to treat cancer, orphan indications and protect healthy tissues from radiation and chemotherapy. The company's product includes entolimod, a recombinant protein which acts as an agonist of toll-like receptor that finds application in radiation mitigation, oncology immunotherapy, and vaccines. It also provides entolimod-oncology, CBLB612, SA-702 - vaccine adjuvant, mobilan, and CBL0137. Cleveland's clinical-stage drug candidates are used for the treatment of cancer and protection from lethal radiation. The company's products are developed using protectan technology and curaxin technology. It partners with the clinic, cancer institute, and others. The company operates in the US and Russia. Cleveland is headquartered in Buffalo, New York, the US.

Cleveland BioLabs Inc (CBLI)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company financial deals that enable you to understand the company expansion/divestiture and fund requirements

The profile enables you to analyze the company financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company business segments' expansion / divestiture strategy

The profile presents deals from the company core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Cleveland BioLabs Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Cleveland BioLabs Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Cleveland BioLabs Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Cleveland BioLabs Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

Cleveland BioLabs Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Cleveland BioLabs Inc, Medical Equipment, Deal Details 10

Equity Offering 10

Cleveland BioLabs Announces Private Placement Of Shares For US$7 Million 10

Cleveland BioLabs Completes Public Offering Of Units For US$17 Million 11

Cleveland BioLabs Completes Registered Direct Offering Of US$23.5 Million 12

Cleveland BioLabs Inc-Key Competitors 14

Key Employees 15

Locations And Subsidiaries 16

Head Office 16

Other Locations & Subsidiaries 16

Recent Developments 17

Financial Announcements 17

May 15, 2017: Cleveland BioLabs Reports First Quarter 2017 Financial Results and Development Progress 17

Feb 22, 2017: Cleveland BioLabs Reports 2016 Financial Results and Development Progress 19

Nov 14, 2016: Cleveland BioLabs Reports Third Quarter 2016 Financial Results and Development Progress 21

Aug 15, 2016: Cleveland BioLabs Reports Second Quarter 2016 Financial Results and Development Progress 22

May 16, 2016: Cleveland BioLabs Reports First Quarter 2016 Financial Results and Development Progress 23

Feb 22, 2016: Cleveland BioLabs Reports 2015 Financial Results and Development Progress 24

Corporate Communications 26

Jul 12, 2016: Cleveland BioLabs Announces Board Resignations 26

Appendix 27

Methodology 27

About GlobalData 27

Contact Us 27

Disclaimer 27


List Of Figure

List of Figures

Cleveland BioLabs Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Cleveland BioLabs Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Cleveland BioLabs Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Cleveland BioLabs Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Cleveland BioLabs Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Cleveland BioLabs Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

Cleveland BioLabs Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Cleveland BioLabs Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

Cleveland BioLabs Inc, Medical Equipment, Key Facts, 2016 1

Cleveland BioLabs Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Cleveland BioLabs Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Cleveland BioLabs Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Cleveland BioLabs Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Cleveland BioLabs Inc, Deals By Market, 2011 to YTD 2017 8

Cleveland BioLabs Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Cleveland BioLabs Announces Private Placement Of Shares For US$7 Million 10

Cleveland BioLabs Completes Public Offering Of Units For US$17 Million 11

Cleveland BioLabs Completes Registered Direct Offering Of US$23.5 Million 12

Cleveland BioLabs Inc, Key Competitors 14

Cleveland BioLabs Inc, Key Employees 15

Cleveland BioLabs Inc, Subsidiaries 16

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Cleveland BioLabs Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.